Posted by ABMN Staff on May 19th, 2024
Swiss National Bank reduced its position in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 9.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 282,600 shares of the biopharmaceutical...
More of this article »